1Zaloga GP, Roberts PR. Bedside placement of enteral feeding tubes in the intensive care unit. Crit Care Med, 1998, 26 (6): 987-988.
2Sarna SK, Soergel KH, Koch TR, et al. Gastrointestinal motor effects of erythromycin in humans. Gastroenterology, 1991, 101 (6): 1488-1496.
3Heiselman DE, Hofer T, Vidovich RR. Enteral feeding tube placement success with intravenous metoclopramide administration in ICU patients. Chest, 1995, 107 (6): 1686-1688.
4Urbain JLC, Vantrappen G, Janssens J, et al. Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids. J Nucl Med, 1990, 31 (9): 1490-1493.
5Hardman JG, Limbird LE. Goodman ＆ Gilman's the pharmaco logical basis of therapeutics 10th ed. New York: Mcgraw Hill, 2001. 1042-1044.
6Itoh Z, Nakaya M, Suzuki T, et al. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol, 1984, 247 (6 Pt 1): G688-G694.
7Tomomasa T, Kuroume T, Arai H, et al. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci, 1986, 31 (2): 157-161.
8Peeters T, Matthijs G, Depoortere I, et al. Erythromycin is a motilin receptor agonist. Am J Physiol, 1989, 257 (3 Pt 1): G470-G474.
8Carvalho P,Knight LL,Olsom RD,et al.Effect of erythromycin on the rabbit pleura,it potential roleas a pleural solerosant.Am J Respis Crit Care[J].Med,2000,156(10):1228-1234.
9Oda J,Kadota J,Kohao S,et al.Erythromyein inhibits neutrophil chemo taris in bronehoalveoli of diffuse panbron chiolitis.chest,1994,106(8):1116-1123.
10Szafiec SV.The mechanism and effect of eryhromycin in development of pukmonary fibrosis[J].Am Rev Respir Dis,2000,41(5):893-899.
